The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects
Status:
Completed
Trial end date:
2020-11-08
Target enrollment:
Participant gender:
Summary
The study is a randomized, single-blind, placebo-controlled, multiple-dose escalation Phase I
trials. 2 dose groups were designed, 12 subjects in each dose group.The drug was administered
single dose and multiple doses.